home / stock / itos / itos news


ITOS News and Press, iTeos Therapeutics Inc. From 11/08/23

Stock Information

Company Name: iTeos Therapeutics Inc.
Stock Symbol: ITOS
Market: NASDAQ
Website: iteostherapeutics.com

Menu

ITOS ITOS Quote ITOS Short ITOS News ITOS Articles ITOS Message Board
Get ITOS Alerts

News, Short Squeeze, Breakout and More Instantly...

ITOS - Expected earnings - iTeos Therapeutics Inc.

iTeos Therapeutics Inc. (ITOS) is expected to report $-1.2 for Q3 2023

ITOS - iTeos Therapeutics GAAP EPS of -$0.90 beats by $0.30

2023-11-07 08:26:49 ET More on iTeos Therapeutics iTeos Therapeutics: Trying Hard Where The Big Guys Might Still Fail iTeos Therapeutics And The TIGIT Ticket To Cancer's Downfall Seeking Alpha’s Quant Rating on iTeos Therapeutics Historical earnings da...

ITOS - iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

- Initiation of GALAXIES H&N-202, a Phase 2 platform study assessing TIGIT:PD-1 doublet and other novel IO combinations, including a CD96 triplet in HNSCC - Completed enrollment of monotherapy dose escalation arm in TIG-007 Phase 2 trial in multiple myeloma - Completed enrollment ...

ITOS - iTeos Therapeutics: Trying Hard Where The Big Guys Might Still Fail

2023-11-04 09:00:00 ET Summary iTeos Therapeutics is a clinical-stage biotech focused on developing immunotherapies for solid tumors, with a focus on non-small cell lung cancer (NSCLC). Their most advanced project is belrestotug, an antibody targeting the TIGIT immune checkpoint, ...

ITOS - NCR Atleos to replace iTeos Therapeutics in S&P SmallCap 600

2023-10-11 18:04:12 ET S&P Dow Jones Indices said Wednesday that NCR Atleos ( NATL ) will replace iTeos Therapeutics ( ITOS ) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 18. iTeos Therapeutics is no longer representative of t...

ITOS - NCR Atleos Set to Join S&P SmallCap 600

NCR Atleos Set to Join S&P SmallCap 600 NCR Atleos Set to Join S&P SmallCap 600 PR Newswire NEW YORK , Oct. 11, 2023 /PRNewswire/ -- NCR Atleos Corp. (NYSE: NATL) will replace iTeos Therapeutics Inc. (NASD: ITOS) in the S&P SmallCap 600 effective ...

ITOS - iTeos to Participate in Upcoming Investor Conferences

WATERTOWN, Mass. and GOSSELIES, Belgium, Sept. 06, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced that company m...

ITOS - ITOS, ADTX and LASE among mid-day movers

2023-08-23 13:11:49 ET Gainers: VCI Global Limited ( VCIG ) +107% . Mercurity Fintech Holding ( MFH ) +44% . Apellis Pharmaceuticals ( APLS ) +32% . iTeos Therapeutics ( ITOS ) +27% . Hitek Global ( HKIT ) +26% . Aditxt ( A...

ITOS - ITOS, APLS and TIVC among top healthcare movers

2023-08-23 10:12:08 ET More on Healthcare sector XLV Vs. VHT: A Head-To-Head Healthcare ETF Comparison XLV: The Powerhouse ETF Driving Health And Wealth BlackRock spotlights healthcare as an opportunity with recession talks in the air BofA experiences its thi...

ITOS - Turkcell Iletisim Hizmetleri, Apellis Pharmaceuticals, Manchester United among premarket gainers' pack

2023-08-23 08:47:02 ET VCI Global ( VCIG ) +61% after announces visionary collaboration with Microsoft Azure OpenAI . iTeos Therapeutics ( ITOS ) +37% in reaction as Roche send anti-TIGIT developers higher after mistakenly-released cancer drug data . Arcus ...

Previous 10 Next 10